Announcements
- 2026.02.06 VOLUNTARY ANNOUNCEMENT FDA APPROVAL FOR PIVOTAL TRIAL OF LUX-VALVE PLUS
- 2026.02.05 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026
- 2026.01.26 INSIDE INFORMATION FORECAST OF THE GROUP'S ANNUAL REVENUE FOR THE FIRST YEAR OF COMMERCIALIZATION
- 2026.01.07 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025
- 2025.12.30 Articles of Association
- 2025.12.30 POLL RESULTS OF THE 2025 THIRD EXTRAORDINARY GENERAL MEETING
- 2025.12.29 VOLUNTARY ANNOUNCEMENT SUBMISSION OF THE REGISTRATION APPLICATION FOR CE MARK OF JENSCLIP
- 2025.12.15 SUPPLEMENTAL ANNOUNCEMENT REGARDING CANCELLATION OF BOOK CLOSURE PERIOD
- 2025.12.12 PROXY FORM FOR THE 2025 THIRD EXTRAORDINARY GENERAL MEETING TO BE HELD ON DECEMBER 30, 2025
- 2025.12.12 NOTICE OF THE 2025 THIRD EXTRAORDINARY GENERAL MEETING
Privacy Law Copyright © Jenscare Scientific Co., Ltd. All rights reserved. 网站备案/许可证号：浙ICP备17016094号
